Additional Benefits of Tiotropium on Stable COPD Management.

被引：0
|
作者：
Kim, H. O. [1 ]
Ha, E. S. [1 ]
Lee, K. J. [1 ]
Lee, E. J. [1 ]
Jung, K. H. [1 ]
Kang, E. H. [1 ]
Lee, S. Y. [1 ]
Lee, S. Y. [1 ]
Kim, J. H. [1 ]
Shin, C. [1 ]
In, K. H. [1 ]
Shim, J. J. [1 ]
Kang, K. H. [1 ]
Yoo, S. H. [1 ]
机构：
[1] Korea Univ, Coll Med, Seoul 136705, South Korea
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A4561
引用
收藏
页数：1
相关论文
共 50 条
  • [1] COPD Maintenance Therapy with Tiotropium/Olodaterol Compared with Tiotropium: An Analysis in the Absence of Additional ICS Therapy
    Calverley, Peter M. A.
    Hoz, Alberto de la
    Xue, Wenqiong
    Ferguson, Gary T.
    Miravitlles, Marc
    [J]. COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 17 (05) : 477 - 484
  • [2] Airway inflammation and tiotropium treatment in stable COPD patients
    Ozol, Duygu
    Karamanli, Harun
    Uysal, Sema
    Yigitoglu, Muhammet Ramazan
    Yildirim, Zeki
    [J]. TURKISH JOURNAL OF MEDICAL SCIENCES, 2014, 44 (05) : 804 - 808
  • [3] Benefits of Tiotropium/Olodaterol Over Tiotropium Alone in Delaying Clinically Significant Deterioration in Patients with COPD
    Rabe, K. F.
    Chalmers, J. D.
    Miravitlles, M.
    Kocks, J.
    Tsiligianni, I.
    de la Hoz, A.
    Xue, W.
    Wedzicha, J. A.
    Singh, D.
    Ferguson, G. T.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [4] The functional impact of adding salmeterol and tiotropium in patients with stable COPD
    Cazzola, M
    Centanni, S
    Santus, P
    Verga, M
    Mondoni, M
    di Marco, F
    Matera, MG
    [J]. RESPIRATORY MEDICINE, 2004, 98 (12) : 1214 - 1221
  • [5] The spirometric efficacy of once daily dosing with tiotropium in stable COPD
    Casaburi, R
    Serby, CW
    Menjoge, SS
    Witek, TJ
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A524 - A524
  • [6] Benefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPD
    Hanania, Nicola A.
    Crater, Glenn D.
    Morris, Andrea N.
    Emmett, Amanda H.
    O'Dell, Dianne M.
    Niewoehner, Dennis E.
    [J]. RESPIRATORY MEDICINE, 2012, 106 (01) : 91 - 101
  • [7] BENEFITS OF TIOTROPIUM/OLODATEROL OVER TIOTROPIUM AT DELAYING CLINICALLY SIGNIFICANT EVENTS IN PATIENTS WITH COPD CLASSIFIED AS GOLD B
    Buhl, R.
    McGarvey, L.
    Korn, S.
    Ferguson, G. T.
    Groenke, L.
    Hallmann, C.
    Voss, F.
    Rabe, K. F.
    Maltais, F.
    [J]. THORAX, 2016, 71 : A251 - A252
  • [8] Management of stable COPD
    van der Valk, P
    Monninkhof, E
    van der Palen, J
    Zielhuis, G
    van Herwaarden, C
    [J]. PATIENT EDUCATION AND COUNSELING, 2004, 52 (03) : 225 - 229
  • [9] BENEFITS OF TIOTROPIUM/OLODATEROL OVER TIOTROPIUM AT DELAYING CLINICALLY SIGNIFICANT EVENTS IN PATIENTS WITH COPD CLASSIFIED AS GOLD B
    不详
    [J]. THORAX, 2016, 71 : A272 - A273
  • [10] Benefits of adding fluticasone propionate/salmeterol to tiotropium in COPD: A meta-analysis
    Liu, Yun
    Shi, Hongyang
    Sun, Xiuzhen
    Zhang, Dexin
    Zhang, Yuping
    Yang, Kunzheng
    Mi, Liehan
    Li, Manxiang
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2014, 25 (05) : 491 - 495
12345